Skip to main content

Take the fast track to becoming a V3 and V3+ expert

Join us Feb. 13 at 11 a.m. ET for “Breaking Barriers with Digital Health Technologies,” unveiling new resources to advance CRS risk prediction and support DHT development. Don’t miss it!

AARDEX V3+ case study

“Usability of digital adherence solutions is the key to success in achieving comprehensive patient data on drug exposure.” — Oana Paun, Quality Assurance Manager, AARDEX Group